We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Parallel Tracking i-biomarkerT Development with Drug Development for Maximum Benefit

Video   Jul 07, 2015

 

Molecular imaging is increasingly being used to support decision-making in early-stage drug development, particularly in the CNS. Providing invaluable information on the so-called ‘three pillars of drug survival’, namely tissue delivery, target engagement and pharmacological effect, it can be seen as a kind of precision pharmacology However, a lack of appreciation of when and how to use imaging and a lack of suitable tools means imaging is often an afterthought and employed in a post-mortem of drug failure. Timely development of imaging biomarkers will ensure the full translational value of this technology can be realised 

 
 
 
 

Recommended Videos

Operetta CLS High-Content Analysis System

Video

The Operetta CLS system is part of PerkinElmer's comprehensive HCS portfolio – from HCS systems and microplates to automation and informatics.

WATCH NOW

A revolution in the world of X-Ray Diffraction

Video

With the 3rd generation Empyrean, Malvern Panalytical has now redefined the concept of a multipurpose diffractometer: the newly designed MultiCore Optics enable the largest variety of measurements without any manual intervention.

WATCH NOW

New Bacterial Enzymes Could Revolutionize Blood Donations

Video

Blood banks need a constant supply of donors to maintain their supply, but some enzymes that are already in our bodies might be able to help!
Video via Scishow

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Analysis & Separations Diagnostics Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE